title: The role of endoscopic bladder tumour assessment in the management of patients subjected to transurethral bladder tumour resection.
abstract: Despite complete resection, non-muscle invasive bladder cancers tend to recur. Therefore, their risk stratification was implemented to select adjuvant therapy. Immediate intravesical chemotherapeutic instillations were shown to decrease the risk of recurrence in those with low-risk disease. The purpose of the study was to determine the role of endoscopic assessment in the management of patients subjected to transurethral resection of the bladder tumour (TURBT). In 262 patients submitted to TURBT due to primary bladder tumour, the size and the number of the lesion(s) were noted and the stage as well as the grade of the tumour(s) were typed. The individual features were then scored according to the European Organisation of Research and Treatment of Cancer 'Bladder Calculator' and the lesions were classified into the low, intermediate and high risk of recurrence group. Clinical evaluation was then compared with pathological report and final triage. Based on the clinical data, 95 (36.25%), 105 (40.07%) and 3 (1.14%) patients were endoscopically assigned to the groups of low, intermediate and high risk of recurrence respectively. After pathological report, correct risk stratification was confirmed in 86 (90.5%), 95 (90.5%) and 3 (100%) patients respectively. Endoscopic assessment of bladder cancers allows to accurately establish the risk of recurrence and may facilitate implementation of adjuvant therapy before histological evaluation.
authors.affiliation: Clinical Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
authors.forename: M A
authors.initials: MA
authors.lastname: Skrzypczyk
authors.affiliation: Clinical Department of Urology, Centre of Postgraduate Medical Education, European Health Centre in Otwock, Otwock, Poland.
authors.forename: Ł
authors.initials: Ł
authors.lastname: Nyk
authors.affiliation: Clinical Department of Urology, Centre of Postgraduate Medical Education, European Health Centre in Otwock, Otwock, Poland.
authors.forename: P
authors.initials: P
authors.lastname: Szostek
authors.affiliation: Clinical Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
authors.forename: S
authors.initials: S
authors.lastname: Szempliński
authors.affiliation: Clinical Department of Urology, Centre of Postgraduate Medical Education, European Health Centre in Otwock, Otwock, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Borówka
authors.affiliation: Clinical Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.|Clinical Department of Urology, Centre of Postgraduate Medical Education, European Health Centre in Otwock, Otwock, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Dobruch
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000601:surgery*; D003558:Cystoscopy / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000473:pathology; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D009378:Neoplasms, Multiple Primary / Q000473:pathology / Q000601:surgery*; D018570:Risk Assessment; D047368:Tumor Burden; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000601:surgery*
keywords: bladder cancer; risk stratification; transurethral resection